Centrally acting drug moxonidine decreases reactive oxygen species via inactivation of the phosphoinositide-3 kinase signaling in the rostral ventrolateral medulla in hypertensive rats-Reference-Cited by-同舟云学术

Centrally acting drug moxonidine decreases reactive oxygen species via inactivation of the phosphoinositide-3 kinase signaling in the rostral ventrolateral medulla in hypertensive rats

Published:2016-05 Issue:5 Volume:34 Page:993-1004
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Wang Yang-Kai,Yu Qiang,Tan Xing,Wu Zhao-Tang,Zhang Ru-Wen,Yang Ya-Hong,Yuan Wen-Jun,Hu Qi-Kuan,Wang Wei-Zhong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference56 articles.

1. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.;Ernsberger;J Pharmacol Exp Therap,1993

2. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.;Haxhiu;J Cardiovasc Pharmacol,1994

3. The sympathetic control of blood pressure.;Guyenet;Nat Rev Neurosci,2006

4. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats.;Kishi;Circulation,2004

5. Brain stem NOS and ROS in neural mechanisms of hypertension.;Chan;Antioxid Redox Signal,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role Renin Angiotensin System in Hypertension;The Renin Angiotensin System in Cardiovascular Disease;2023

2. β-Arrestin1 Reduces Oxidative Stress via Nrf2 Activation in the Rostral Ventrolateral Medulla in Hypertension;Frontiers in Neuroscience;2021-04-07

3. Role of the central renin‑angiotensin system in hypertension (Review);International Journal of Molecular Medicine;2021-04-07

4. Calcitriol ameliorated autonomic dysfunction and hypertension by down-regulating inflammation and oxidative stress in the paraventricular nucleus of SHR;Toxicology and Applied Pharmacology;2020-05

5. Quantitative analysis by reversed-phase high-performance liquid chromatography and retinal neuroprotection after topical administration of moxonidine;International Journal of Ophthalmology;2020-03-18